The Santa Clara, Calif.-based company Cardiva Medical Inc. announced April 5 it has received an expanded indication from US FDA for Vascade. The vascular closure system, which was already approved in 2013 for arterial closures, is now also approved for difficult femoral vein closures.
The company argues that not only does this mean better treatment for patients undergoing interventional cardiac catheterization surgery, but also...